Leukemia inhibitory factor modulates interleukin-1β-induced activation of the hypothalamo-pituitary-adrenal axis

Endocrinology

Volumn 139, Issue 5, 1998, Pages 2201-2208

  Auernhammer, Christoph J ^a   Chesnokova, Vera ^a   Melmed, Shlomo ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CYTOKINE; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 6; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HYPOPHYSIS CELL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KNOCKOUT MOUSE; MALE; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031765818     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.5.6017     Document Type: Article

References (53)

1. Gearing DP 1993 The leukemia inhibitory factor and its receptor. Adv Immunol 53:31-58
2. Hibi M, Nakajima K, Hirano T 1996 IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med 74:1-12
3. Taga T 1997 The signal transducer gp130 is shared by interleukin-6 family of haematopoietic and neurotrophic cytokines. Ann Med 29:63-72
4. Zhang XG, Gu JJ, Lu ZY, Yasukawa K, Yancopoulos GD, Turner K, Shoyab M, Taga T, Kishimoto T, Bataille R, Klein B 1994 Ciliary neurotrophic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth fcators for human myeloma cell lines using the interleukin 6 signal transducer gp130. J Exp Med 177:1337-1342
5. Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbierei G, Pellegrini S, Ihle JN, Yancopoulos GD 1994 Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6β receptor components. Science 263:92-95
6. Ferrara N, Winer J, Henzel WJ 1992 Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor. Proc Natl Acad Sci USA 89:698-702
7. Akita S, Webster J, Ren SG, Takino H, Said J, Zand O, Melmed S 1995 Human and murine pituitary expression of leukemia inhibitory factor. J Clin Invest 95:1288-1298
8. Wang Z, Ren S-G, Melmed S 1996 Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuroendocrine interface. Endocrinology 137:2947-2953
9. Shimon I, Yan X, Ray DW, Melmed S 1997 Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. J Clin Invest 100:357-363
10. Ray DW, Ren SG, Melmed S 1996 Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J Clin Invest 97:1852-1859
11. Bousquet C, Ray DW, Melmed S 1997 A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy. J Biol Chem 272:10551-10557
12. Chesnokova V, Auernhammer CJ, Melmed S 1998 Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response. Endocrinology 139:2209-2216
13. Akita S, Conn PM, Melmed S 1996 Leukemia inhibitory factor (LIF) induces acute adrenocorticotrophic hormone (ACTH) secretion in fetal rhesus macaque primate: a novel dynamic test of pituitary function. J Clin Endocrinol Metab 81:4170-4178
14. Akita S, Readhead C, Stefaneanu L, Fine J, Tampanaru-Sarmesiu A, Kovacs K, Melmed S 1997 Pituitary-directed leukemia inhibitory factor transgene forms Rathke's cleft cysts and impairs pituitary function. A model for human pituitary Rathke's cysts. J Clin Invest 99:2462-2469
15. Akita S, Malkin J, Melmed S 1996 Disrupted murine leukemia inhibitory factor (LIF) gene attenuates adrenocorticotropic hormone (ACTH) secretion. Endocrinology 137:3140-3143
16. Turnbull AV, Rivier C 1995 Regulation of the HPA axis by cytokines. Brain Behav Immun 9:253-275
17. Chrousos GP 1995 The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351-1362
18. Besedovsky HO, Del Rey A 1996 Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17:64-102
19. Ray D, Melmed S 1997 Pituitary cytokine and growth factor expression and action. Endocr Rev 18:206-228
20. Muramami N, Fukata J, Tsukada T, Kobayashi H, Ebisui O, Segawa H, Muro S, Imura H, Nakao K 1993 Bacterial lipopolysaccharide-induced expression of interleukin-6 messenger ribonucleic acid in the rat hypothalamus, pituitary, adrenal gland, and spleen. Endocrinology 133:2574-2578
21. Spangelo BL, Jarvis WD, Judd AM, MacLeod RM 1991 Induction of interleukin-6 release by interleukin-1 in rat anterior pituitary cells in vitro: evidence for an eicosanoid-dependent mechanism. Endocrinology 129:2886-2894
22. Perlstein RS, Whitnall MH, Abrams JS, Mougey EH, Neta R 1993 Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 132:946-952
23. Rivier C, Chizzonite R, Vale W 1989 In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology 125:2800-2805
24. Fantuzzi G, Zheng H, Faggioni R, Benigni F, Ghezzi P, Sipe JD, Shaw AR, Dinarello CA 1996 Effect of endotoxin in IL-1β-deficient mice. J Immunol 157:291-296
25. Benigni F, Fantuzzi G, Sacco S, Sironi M, Pozzi P, Dinarello CA, Sipe JD, Poli V, Cappelletti M, Paonessa, G, Pennica D, Panayotatos N, Ghezzi P 1996 Six different cytokines that share gp130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. Blood 87:1851-1854
26. Fattori E, Cappelletti M, Costa P, Sellitto C, Cantoni L, Carelli M, Faggioni R, Fantuzzi G, Ghezzi P, Poli V 1994 Defective inflammatory response in interleukin 6-deficient mice. J Exp Med 180:1243-1250
27. Hamilton J, Waring P, Filonzi E 1993 Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-α. J Immunol 150:1496-1502
28. Campbell I, Waring P, Novak U, Hamilton J 1993 Production of leukemia inhibitory factor by human articular chondrocytes and cartilage in response to interleukin-1 and tumor necrosis factor α. Arthritis Rheum 35:790-794
29. Grosset C, Jazwiec B, Taupin J-L, Liu H, Richard S, Mahon F-X, Reiffers J, Moreau J-F, Ripoche J 1995 in vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1a and glucocorticoids. Blood 86:3763-3770
30. Derigs H, Boswell H 1993 LIF mRNA expression is transcriptionally regulated in murine bone marrow stromal cells. Leukemia 7:630-634
31. Arici A, Engin O, Attar E, Olive D 1994 Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab 80:1908-1915
32. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ 1992 Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature 359:76-79
33. Takao T, Hashimoto K, De Souza EB 1995 Modulation of interleukin-1 receptors in the neuro-endocrine-immune axis. Int J Dev Neurosci 13:167-178
34. Stahl J, Gearing DP, Willson TA, Brown MA, King JA, Gough NM 1990 Structural organization of the genes for murine and human leukemia inhibitory factor. J Biol Chem 265:8833-8841
35. Rathjen PD, Toth S, Willis A, Heath JK, Smith AG 1990 Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage. Cell 62:1105-1114
36. Gough NM, Willson TA, Stahl J, Brown MA 1992 Molecular biology of the leukemia inhibitory factor gene. Ciba Found Symp 167:24-38
37. Parnet P, Brunke DL, Goujon E, Mainard JD, Biragyn A, Arkins S, Dantzer R, Kelley KW 1993 Molecular identification of two types of interleukin-1 receptors in the murine pituitary gland. J Neuroendocrinol 5:213-219
38. Bristulf J, Bartfai T 1995 Interleukin-1β and tumor necrosis factor-α stimulate the mRNA expression of interleukin-1 receptors in mouse anterior pituitary AtT-20 cells. Neurosci Lett 187:53-56
39. Dinarello CA 1996 Biological basis for interleukin-1 in disease. Blood 87:2095-2147
40. Kobayashi H, Fukata J, Murakami N, Usui T, Ebisui O, Muro S, Hanaoka I, Inoue K, Imura H, Nakao K 1997 Tumor necrosis factor receptors in the pituitary cells. Brain Res 758:45-50
41. Arzt E, Stelzer G, Renner U, Lange M, Muller OA, Stalla GK 1992 Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures. J Clin Invest 90:1944-1951
42. Fukata J, Usui T, Naitoh Y, Nakai Y, Imura H 1989 Effects of recombinant human interleukin-1α, -1β, 2 and 6 on ACTH synthesis and release in the mouse pituitary tumour cell line AtT-20. J Endocrinol 122:33-39
43. Velkeniers B, Vergani P, Trouillas J, D'Haens J, Hooghe RJ, Hooghe-Peters EL 1994 Expression of IL-6 mRNA in normal rat and human pituitaries and in human pituitary adenomas. J Histochem Cytochem 42:67-76
44. Ye J, Young HA 1997 Negative regulation of cytokine gene transcription. FASEB J 11:825-833
45. Carter DA 1995 Leukemia inhibitory factor expression in cultured rat anterior pituitary is regulated by glucocorticoids. J Neuroendocrinol 7:623-628
46. Gwosdow AR, O'Connell NA, Abou-Samra AB 1994 Interleukin-1 increases protein kinase A activity by a cAMP-independent mechanism in AtT-20 cells. Am J Physiol 266:E79-E84
47. Kehrer P, Tumill D, Dayer J-M, Muller AF, Gaillard RC 1988 Human recombinant interleukin-1β and -α, but not recombinant tumor necrosis factor alpha stimulate ACTH release from rat anterior pituitary cells in vitro in a prostaglandin E2 and cAMP independent manner. Neuroendocrinology 48:160-166
48. Hashimoto K, Nishioka T, Tojo C, Takao T 1995 Nitric oxide plays no role in ACTH release induced by interleukin-1β, corticotrophin-releasing hormone, arginine vasopressin and phorbol myristate acetate in rat anterior pituitary cell cultures. Endocr J 42:435-439
49. van der Meer MJM, Hermus RMM, Pesman GJ, Sweep CGJF 1996 Effects of cytokines on pituitary b-endorphin and adrenal corticosterone release in vitro. Cytokine 8:238-247
50. Renner U, Newton CJ, Pagotto U, Sauer J, Arzt E, Stalla GK 1995 Involvement of interleukin-1 and interleukin-1 receptor antagonist in rat pituitary cell growth regulation. Endocrinology 136:3186-3193
51. Aoki Y, Iwasaki Y, Katahira M, Oiso Y, Saito H 1997 Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. I. Effects of the common secretagogues. Endocrinology 138:1923-1929
52. Banks WA, Oritz L, Plotkin SR, Kastin AJ 1991 Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 259:988-996
53. Stefana B, Ray DW, Melmed S 1996 Leukemia inhibitory factor induces differentiation of pituitary corticotroph function: an immuno-neuroendocrine phenotypic switch. Proc Natl Acad Sci USA 93:12502-12506